Surgical robots' awkward adolescenceStudies


Surgical robots' awkward adolescence
Studies call their effectiveness into question; now an FDA recall looms.

FDA recalls antibiotic, cites error, health risk
The Food and Drug Administration (FDA) has ordered the recall of an antibiotic drug manufactured in India, citing findings that it poses a safety risk and adverse health consequences.

DePuy Knee Sleeve Lawyers Help: Resource4thePeople Comments on FDA Adverse Event Reports on Knee Sleeve Device
Latest government figures show 10 reports, including 8 fractures. Resource4thePeople s national network of attorneys continue offer of free consultations to consumers involving allegations linked to FDA recall of DePuy diaphyseal sleeves. (PRWeb December 16, 2013) Read the full story at http://www.prweb.com/releases/2013/12/prweb11419067.htm

Surgical robots' awkward adolescenceStudies


Surgical robots' awkward adolescence
Studies call their effectiveness into question; now an FDA recall looms.

FDA: Idaho Noted Yeast in Yogurt Before Recall
FDA report: Idaho agriculture inspector found yeast in yogurt months before Chobani recall

FDA: Idaho knew Chobani yogurt was tainted before recall
TWIN FALLS, Idaho A U.S. Food and Drug Administration report says the Idaho State Department of Agriculture detected abnormalities in yogurt at a Chobani facility two months before the company issued a recall, but state officials say that's not true.

DePuy Knee Sleeve Lawyers Update: Resource4thePeople Clarifies Effect of Huge DePuy Court Settlement
Proposed $4 billion settlement of DePuy hip implant lawsuits alleging design defects will not affect knee sleeve claims. Resource4thePeople s national network of attorneys will continue to offer free consultations to consumers involving allegations linked to FDA recall of DePuy diaphyseal sleeves. (PRWeb November 22, 2013) Read the full story at http://www.prweb.com/releases/2013/11 ...
 
Notify me with the latest breaking FDA News
fda approvals Tell us where to send your notifications:

FDA Starts Regulating Compounding


FDA Starts Regulating Compounding Pharmacies
Title: FDA Starts Regulating Compounding Pharmacies Category: Health News Created: 12/2/2013 4:36:00 PM Last Editorial Review: 12/3/2013 12:00:00 AM

Meningitis Outbreaks Call For FDA Leadership. Don't Hold Your Breath.
There is no approved MenB vaccine in the United States.

Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R)
-- FDA Issues Final Approval of 15 mg, With 180 Days of Exclusivity, and 30 mg; and
 

©2010 FDA-News.com. All rights reserved.
To learn about medicare including medicare part a, please visit our sister site Medicare Help Guide.